Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance
Pharmacoepidemiology and drug safety · 2026 Nov · Melamed B, Parsi-Zahabi M, Omrani MA et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 07:00 ETSource: Pharmacoepidemiology and drug safety
From the source
Read at pubmed.ncbi.nlm.nih.govSemaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance
Pharmacoepidemiology and drug safety · 2026 Nov · Melamed B, Parsi-Zahabi M, Omrani MA et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42946127/
